RedHill Biopharma (RDHL) Raw Materials (2018 - 2024)

RedHill Biopharma (RDHL) has 7 years of Raw Materials data on file, last reported at $513000.0 in Q4 2024.

• On a quarterly basis, Raw Materials fell 38.04% year-over-year to $513000.0 in Q4 2024; TTM through Dec 2024 was $513000.0, a 38.04% decrease from a year earlier, with the FY2024 full-year figure at $513000.0, down 38.04% from the prior year.
• Raw Materials for Q4 2024 stood at $513000.0, down from $828000.0 in the prior quarter.
• Over the last five years, Raw Materials for RDHL reached as high as $3.0 million in Q4 2021 and fell as low as $513000.0 in Q4 2024.
• Historically, Raw Materials has averaged $1.6 million across 5 years, with a median of $1.8 million in 2020.
• Across the five-year window, Raw Materials surged 68.08% in 2021 and sank 53.92% in 2023, its largest moves.
• Year by year, Raw Materials stood at $1.8 million in 2020, then jumped by 68.08% to $3.0 million in 2021, then slumped by 40.34% to $1.8 million in 2022, then slumped by 53.92% to $828000.0 in 2023, then tumbled by 38.04% to $513000.0 in 2024.
• Per Business Quant data, the three most recent Raw Materials figures were $513000.0 in Q4 2024, $828000.0 in Q4 2023, and $1.8 million in Q4 2022.